Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Lucentis

Lucentis contains the active ingredient ranibizumab. It is only available with a doctor’s prescription.

Lucentis is used to treat damage to the retina, which is the inside back wall of your eyeball. It stops the abnormal growth new blood vessels in the retina, and stops any blood vessels leaking. These are problems in eye conditions such as wet age-related macular oedema and macular oedema.

Lucentis is only available as an injection. It is given by your eye specialist into your eye under local anaesthetic, usually once every month.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: ranibizumab

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Lucentis 2.3 mg/0.23 mL injection solution, 0.23 mL vial

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Lucentis (ranibizumab) is indicated in adults for:,- the treatment of neovascular (wet) age-related macular degeneration (AMD).,- the treatment of visual impairment due to choroidal neovascularisation.,- the treatment of visual impairment due to choroidal neovascularisation (CNV) secondary to pathologic myopia (PM).,- the treatment of visual impairment due to diabetic macular oedema (DME).,- the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (RVO).

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Clear, colourless to pale yellow solution
Dosage Form Injection, solution
Route of administration Intravitreal-Within The Vitreous Cavity Of The Eye
Medicine schedule
1 x vial: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store at 2 to 8 degrees Celsius
Storage conditions Do not Freeze,Protect from Light
Life time 36 Months
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 May 2018

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 3 results

Lucentis Vial -

Lucentis Vial - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Macular Degeneration | myVMC

Macular degeneration affects the nerves in the macula, the central portion of the eye's retina. It affects high acuity vision needed for sharp focus.

Read more on myVMC – Virtual Medical Centre website

Diabetic Macular Oedema | myVMC

Diabetic macular oedema is a sight-threatening eye condition

Read more on myVMC – Virtual Medical Centre website

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo